Date: Wednesday, September 20, 2017
Time: 10am PDT (1pm EDT)
Duration: 60 minutes

CROs today are faced with challenges beyond growing and maintaining the business of providing outsourcing services. Within the study conduct phase of clinical trials, they are responsible for quality data, accurate and timely communications, and best practices in reducing risk in managing studies, sites, CRAs and portfolios for their sponsor clients.

This webinar will present findings from a new benchmark survey conducted across leading CRO executives and project team members, to shed light on the challenges associated with managing increasing complexity of data, maintaining milestones at greater economy, and addressing new requirements from guidance such as ICH E6 (R2).

The webinar will share results from questions such as:

  • What are the greatest limitations to a successful sponsor relationship?
  • How are you planning to address ICH E6 (R2) with your sponsor clients?
  • How can the process of creating and maintaining Quality Agreements and Vendor Oversight plans be improved?

Join Tracy Hammett of Sarah Cannon Research Institute and Comprehend Systems for an in-depth review of the results from this Benchmark Survey and a short demonstration of how Clinical Intelligence meets risk management and collaboration goals.


Featured Speakers:


Julie Peacock, Clinical Intelligence Expert, Comprehend

Closely aligned with customers and the sales organization, Julie focuses on enabling prospects and customers on Comprehend’s Clinical Intelligence solutions. She manages go to market strategy, sales enablement, and product marketing.

Prior to Comprehend, Julie spent 18 years at Oracle Corporation in the enterprise application space where she managed strategy, field enablement and launch activities for a series of BtoB solutions. Julie holds a bachelor’s degree in Marketing from Auburn University.

Mike Blume.jpg

Mike Blume, Executive Director CRO Channel, Comprehend

Mike is responsible for managing our CRO channel at Comprehend.  He has spent his career in clinical development areas growing customers and sales organizations.

His 10+ years of clinical experience includes contributions at both INC Research and inVentiv Health in a series of management roles.


Tracey Hammett, Director of Clinical Development, Sarah Cannon

Tracey has more than 20 years of experience in clinical research at both a Sponsor and CRO and currently serves as Director, Clinical Development as Sarah Cannon Development Innovations.

She has extensive knowledge of early oncology drug development and is an expert in leading and managing cross-functional, global working teams to design, conduct, and deliver projects.  She is an advocate of data-driven processes and quality metrics in conducting clinical trials.  Tracey has a degree in nursing and graduated from the Oxford School of Nursing in the UK.